Asahi Kasei's $1.1 billion power move - acquiring Calliditas to dominate global healthcare
In a bold move set to reshape the global healthcare landscape, Asahi Kasei Corp. announced its intent to acquire Swedish drug maker Calliditas Therapeutics AB through a voluntary tender offer.